SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

Prior authorizations draining time, energy from many cancer patients

4.

New drug combination shows good results in patients with HPV-negative head and neck cancer

5.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot